Case number 1:19-cv-00055
Bristol-Myers Squibb Company v. Unichem Laboratories, Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 13, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See Final Judgment in lead case no. 17-374-LPS at D.I. 739) Associated Cases: 1:17-cv-00380-LPS, 1:17-cv-00382-LPS, 1:17-cv-00408-LPS, 1:19-cv-00055-LPS (ntl) |
| Feb 5, 2019 | 9 | Answer to Counterclaim (4) Docket Text: ANSWER to [7] Answer to Complaint, Counterclaim by Bristol-Myers Squibb Company.(Farnan, Brian) |
| Jan 23, 2019 | 7 | Answer to Complaint (8) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses and, COUNTERCLAIM against Bristol-Myers Squibb Company by Unichem Laboratories, Ltd..(Phillips, John) |
| Jan 23, 2019 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Unichem Laboratories, Ltd.. (Phillips, John) |
| Jan 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [6] STIPULATION and [Proposed] Order to Set Time to Answer, Move or Otherwise Respond to Complaint and to Consolidate Action filed by Bristol-Myers Squibb Company. Signed by Judge Leonard P. Stark on 1/18/19. (ntl) |
| Jan 22, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-00374-LPS. (ntl) |
| Jan 16, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Jan 16, 2019 | 6 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Set Time to Answer, Move or Otherwise Respond to Complaint and to Consolidate Action by Bristol-Myers Squibb Company. (Farnan, Michael) |
| Jan 10, 2019 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (ceg) |
| Jan 9, 2019 | 1 | Complaint (6) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Unichem Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2540514.) - filed by Bristol-Myers Squibb Company. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(ceg) |
| Jan 9, 2019 | 1 | Exhibit A (157) |
| Jan 9, 2019 | 1 | Exhibit B (45) |
| Jan 9, 2019 | 1 | Civil Cover Sheet (1) |
| Jan 9, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Jan 9, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/24/2018. Date of Expiration of Patent: 11/21/2026.Thirty Month Stay Deadline: 6/24/2021. (ceg) |
| Jan 9, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,967,208 B2. (ceg) |
| Jan 9, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (ceg) |
